2 hasil untuk "Burak Doganyigit"
Menampilkan 1–2 · 0,39 detik · RSS
-
Artikel Jurnal
Investigating patient eligibility for anti-amyloid monoclonal antibody treatment of Alzheimer's disease: real-world data from an Austrian psychiatric memory clinic population
Background Pharmacological treatment options for patients with dementia owing to Alzheimer's disease are limited to symptomatic therapy. Recently, the US Food and Drug Administration approved the monoclonal antibody lecanemab for the treatment of amyloid-positive patients with mild cognitive…
-
Artikel Jurnal
Temporal atrophy together with verbal encoding impairment is highly predictive for cognitive decline in typical Alzheimer’s dementia – a retrospective follow-up study
IntroductionThe increasing prevalence of Alzheimer’s disease (AD) has created an urgent need for rapid and cost-effective methods to diagnose and monitor people at all stages of the disease. Progressive memory impairment and hippocampal atrophy are key features of the most common so-called typical…